Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Heart Circ Physiol ; 289(5): H1923-32, 2005 Nov.
Article in English | MEDLINE | ID: mdl-15951348

ABSTRACT

The mRNA levels for the three alpha1-adrenoceptor subtypes, alpha1A, alpha1B, and alpha1D, were quantified by real-time RT-PCR in arteries from Wistar rats. The alpha1D-adrenoceptor was prominent in both aorta (79.0%) and mesenteric artery (68.7%), alpha1A predominated in tail (61.7%) and small mesenteric artery (73.3%), and both alpha1A- and alpha1D-subtypes were expressed at similar levels in iliac artery. The mRNA levels of the alpha1B-subtype were a minority in all vessels (1.7-11.1%). Concentration-response curves of contraction in response to phenylephrine or relaxation in response to alpha1-adrenoceptor antagonists on maximal sustained contraction induced by phenylephrine were constructed from control vessels and vessels pretreated with 100 micromol/l chloroethylclonidine (CEC) for 30 min. The significant decrease in the phenylephrine potency observed after CEC treatment together with the inhibitory potency displayed by 8-{2-[4-(2-methoxyphenyl)-1-piperazinyl]-8-azaspiro (4,5) decane-7-dionedihydrochloride} (BMY-7378, an alpha1D-adrenoceptor antagonist) confirm the relevant role of alpha1D-adrenoceptors in aorta and iliac and proximal mesenteric arteries. The potency of 5-methylurapidil (an alpha1A-adrenoceptor antagonist) and the changes in the potency of both BMY-7378 and 5-methylurapidil after CEC treatment provided evidence of a mixed population of alpha1A- and alpha1D-adrenoceptors in iliac and distal mesenteric arteries. The low potency of prazosin (pIC50 < 9) as well as the high 5-methylurapidil potency in tail and small mesenteric arteries suggest the main role of alpha1A/alpha1L-adrenoceptors with minor participation of the alpha1D-subtype. The mRNA levels and CEC treatment corroborated this pattern and confirmed that the alpha1L-adrenoceptor could be a functional isoform of the alpha1A-subtype.


Subject(s)
Arteries/metabolism , RNA, Messenger/biosynthesis , Receptors, Adrenergic, alpha-1/biosynthesis , Receptors, Adrenergic, alpha-1/physiology , Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Aorta, Thoracic/drug effects , DNA Primers , Dose-Response Relationship, Drug , Iliac Artery/drug effects , In Vitro Techniques , Muscle Contraction/drug effects , Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/drug effects , Phenylephrine/pharmacology , Protein Isoforms , Rats , Rats, Wistar , Receptors, Adrenergic, alpha-1/drug effects , Reverse Transcriptase Polymerase Chain Reaction
2.
J Nat Prod ; 66(7): 954-7, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12880313

ABSTRACT

A series of O- and/or N-substituted derivatives of (+/-)-coclaurine (1a) were synthesized as simplified structural mimics of the antihypertensive alkaloid tetrandrine (2) and assayed for binding to brain cortical sites labeled with the alpha(1)-adrenergic radioligand [(3)H]prazosin or the calcium channel radioligand [(3)H]diltiazem. The introduction of O-benzyl groups on the coclaurine molecule, which exhibits only adrenergic antagonist activity, led to the appearance of calcium channel blocking activity comparable to that of tetrandrine while retaining adrenolytic activity in the same concentration range. Contraction of aortal rings with noradrenaline or KCl was relaxed more potently by some of these coclaurine derivatives than by tetrandrine, suggesting leads for the development of novel antihypertensive drugs with a dual mechanism of action.


Subject(s)
Alkaloids/chemistry , Alkaloids/chemical synthesis , Benzylisoquinolines/chemistry , Benzylisoquinolines/chemical synthesis , Calcium Channel Blockers/chemical synthesis , Calcium Channel Blockers/pharmacology , Combinatorial Chemistry Techniques , Isoquinolines/chemical synthesis , Isoquinolines/pharmacology , Antihypertensive Agents , Diltiazem/pharmacology , Inhibitory Concentration 50 , Molecular Conformation , Molecular Mimicry , Molecular Structure , Prazosin/pharmacology , Stereoisomerism , Structure-Activity Relationship
3.
Br J Pharmacol ; 135(1): 206-16, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11786496

ABSTRACT

1. The role of a constitutively active population of alpha(1D)-adrenoceptors was analysed in arteries obtained from spontaneously hypertensive rats (SHR) and controls (WKY) divided into three groups: young prehypertensive, adult hypertensive, and adult animals chronically treated with captopril (50 mg kg(-1) per day orally) in order to prevent the hypertensive state. 2. In adult SHR, a significant increase in BMY 7378 potency (not in prazosin potency) was observed in aorta, mesenteric artery, and the first and second branches of the small mesenteric arteries with respect to WKY rats. This difference was not observed in iliac and tail arteries, which suggests an increased functional role of alpha(1D)-adrenoceptors only in some vessels of SHR. 3. The increase in the resting tone (IRT) observed in absence of agonist, inhibited by BMY 7378, that represents the constitutively active population of alpha(1D)-adrenoceptors, was also significantly greater in aorta and mesenteric artery from adult SHR. 4. In young and captopril treated adult animals, no differences between strains with respect to BMY 7378 potency, or IRT were observed. 5. The increase in the functional role of alpha(1D)-adrenoceptors and their constitutive activity observed in hypertension is prevented by captopril treatment. The pathological consequence of this change is the slower rate of recovery of the basal tone after removal of an adrenergic stimulus, observed in vessels from hypertensive animals that had shown an increase in the functionality of constitutively active alpha(1D)-adrenoceptors. This change was not observed in prehypertensive or captopril treated animals.


Subject(s)
Arteries/physiopathology , Hypertension/physiopathology , Receptors, Adrenergic, alpha-1/physiology , Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Age Factors , Animals , Antihypertensive Agents/pharmacology , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiopathology , Arteries/drug effects , Captopril/pharmacology , Dose-Response Relationship, Drug , Hemodynamics/drug effects , Iliac Artery/drug effects , Iliac Artery/physiopathology , In Vitro Techniques , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/physiopathology , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle Relaxation/drug effects , Muscle Relaxation/physiology , Muscle, Smooth, Vascular/physiology , Norepinephrine/pharmacology , Phenylephrine/pharmacology , Piperazines/pharmacology , Prazosin/pharmacology , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Receptors, Adrenergic, alpha-1/drug effects , Tail/blood supply , Vasoconstriction/drug effects , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...